{"id":62239,"date":"2025-11-20T22:08:22","date_gmt":"2025-11-20T21:08:22","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\/"},"modified":"2025-11-20T22:08:22","modified_gmt":"2025-11-20T21:08:22","slug":"hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\/","title":{"rendered":"Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference"},"content":{"rendered":"
\n

GUILFORD, Conn.–(BUSINESS WIRE)–Hyperfine, Inc.<\/a> (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain\u2014the Swoop\u00ae system\u2014today announced plans to present at the upcoming Piper Sandler 37th Annual Healthcare Conference on Thursday, December 4th at 8:10 am Eastern Time (ET).<\/p>\n

<\/a>
<\/a><\/p>\n

\nA live audio webcast and an archive of the recording will be available through the Investors page of Hyperfine, Inc.\u2019s corporate website at https:\/\/investors.hyperfine.io<\/a>.<\/p>\n

\nManagement will also be hosting in-person meetings. To schedule a one-on-one meeting with management, please reach out to your Piper Sandler representative, or the investor contact below.<\/p>\n

\nAbout the Swoop\u00ae Portable MRI Systems<\/b><\/p>\n

\nThe Swoop\u00ae Portable MR Imaging\u00ae Systems are U.S. Food and Drug Administration (FDA) cleared for brain imaging of patients of all ages. They are portable, ultra-low-field magnetic resonance imaging devices for producing images that display the internal structure of the head where full diagnostic examination is not clinically practical. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis.<\/p>\n

\nAbout Hyperfine, Inc.<\/b><\/p>\n

\nHyperfine, Inc. (Nasdaq: HYPR) is the groundbreaking health technology company that has redefined brain imaging with the Swoop\u00ae system\u2014the first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system capable of providing imaging at multiple points of professional care. The mission of Hyperfine, Inc. is to revolutionize patient care globally through transformational, accessible, clinically relevant diagnostic imaging. Founded by Dr. Jonathan Rothberg in a technology-based incubator called 4Catalyzer, Hyperfine, Inc. scientists, engineers, and physicists developed the Swoop\u00ae system out of a passion for redefining brain imaging methodology and how clinicians can apply accessible diagnostic imaging to patient care. For more information, visit HyperfineMRI.com<\/a>.<\/p>\n

\nThe Hyperfine logo, Swoop, and Portable MR Imaging are registered trademarks of Hyperfine, Inc. The Swoop logo, Optive AI logo, and Optive AI are trademarks of Hyperfine, Inc.<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact<\/b>
Devin Zell
\n
Hyperfine
\n
dzell@hyperfine.io<\/a><\/p>\n

\nInvestor Contact<\/b>
Webb Campbell
\n
Gilmartin Group LLC
\n
webb@gilmartinir.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

GUILFORD, Conn.–(BUSINESS WIRE)–Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain\u2014the Swoop\u00ae system\u2014today announced plans to present at the upcoming Piper Sandler 37th Annual Healthcare Conference on Thursday, December 4th at 8:10 am Eastern Time (ET). A live audio … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62239","6":"format-standard","7":"category-industry"},"yoast_head":"\nHyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"GUILFORD, Conn.–(BUSINESS WIRE)–Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain\u2014the Swoop\u00ae system\u2014today announced plans to present at the upcoming Piper Sandler 37th Annual Healthcare Conference on Thursday, December 4th at 8:10 am Eastern Time (ET). A live audio ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-20T21:08:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251120147545\/en\/2375273\/22\/Hyperfine_Logomark_Full_Color_RGB_600px_tall.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference\",\"datePublished\":\"2025-11-20T21:08:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\\\/\"},\"wordCount\":351,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251120147545\\\/en\\\/2375273\\\/22\\\/Hyperfine_Logomark_Full_Color_RGB_600px_tall.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\\\/\",\"name\":\"Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251120147545\\\/en\\\/2375273\\\/22\\\/Hyperfine_Logomark_Full_Color_RGB_600px_tall.jpg\",\"datePublished\":\"2025-11-20T21:08:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251120147545\\\/en\\\/2375273\\\/22\\\/Hyperfine_Logomark_Full_Color_RGB_600px_tall.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251120147545\\\/en\\\/2375273\\\/22\\\/Hyperfine_Logomark_Full_Color_RGB_600px_tall.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference - Pharma Trend","og_description":"GUILFORD, Conn.–(BUSINESS WIRE)–Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain\u2014the Swoop\u00ae system\u2014today announced plans to present at the upcoming Piper Sandler 37th Annual Healthcare Conference on Thursday, December 4th at 8:10 am Eastern Time (ET). A live audio ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\/","og_site_name":"Pharma Trend","article_published_time":"2025-11-20T21:08:22+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251120147545\/en\/2375273\/22\/Hyperfine_Logomark_Full_Color_RGB_600px_tall.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference","datePublished":"2025-11-20T21:08:22+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\/"},"wordCount":351,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251120147545\/en\/2375273\/22\/Hyperfine_Logomark_Full_Color_RGB_600px_tall.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\/","url":"https:\/\/pharma-trend.com\/en\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\/","name":"Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251120147545\/en\/2375273\/22\/Hyperfine_Logomark_Full_Color_RGB_600px_tall.jpg","datePublished":"2025-11-20T21:08:22+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251120147545\/en\/2375273\/22\/Hyperfine_Logomark_Full_Color_RGB_600px_tall.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251120147545\/en\/2375273\/22\/Hyperfine_Logomark_Full_Color_RGB_600px_tall.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/hyperfine-inc-to-participate-in-upcoming-piper-sandler-37th-annual-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62239","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62239"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62239\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62239"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62239"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62239"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}